Definitive Contract HHSN272201700001C
Award Date
12/29/16
Potential Completion Date
12/31/23
Potential Value
$13M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Mriglobal
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a definitive contract valued at $21.88 million to MRIGlobal for the Mycobacterium tuberculosis Quality Assessment Program. Under this cost-plus-fixed-fee contract holding one base year and six option periods extending through November 2030, MRIGlobal will support laboratories conducting clinical trials on tuberculosis. Services will include proficiency...
This is a delivery order awarded to Mriglobal, doing business as Midwest Research Institute, under a $3,500.00 Firm Fixed Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The contract was awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, for the Diagnostics Pre-Clinical Services Program. The contract has a period of performance through June 19, 2030. Mriglobal is a 501(c)(3) not-for-profit research organization that provides scientific...
This is a $13,523,501.30 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Research Institute Of The Mcgill University Health Centre for Tuberculosis Trials Consortium Services. The contract has a period of performance through December 31, 2030 and was awarded on January 1, 2021. It is a cost-no-fee contract to support clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis, including studies of latent TB infection in...
This is a $19,091,009.00 cost-plus-fixed-fee definitive contract awarded by a U.S. government agency to the not-for-profit research organization Mriglobal, doing business as Midwest Research Institute. The contract, which has no set-aside designation, is for research and development work and is set to be completed by November 15, 2005. Mriglobal specializes in areas such as medical countermeasure development, biosafety testing, threat detection technologies, and specialized training programs,...
This is a firm fixed-price delivery order contract awarded by the Washington Headquarters Service, a defense agency, to Mriglobal, a 501(c)(3) not-for-profit research organization doing business as Midwest Research Institute. The contract, valued at $96,840.00, is for special studies work. Mriglobal is a prime contractor that frequently partners with universities, research institutes, and small businesses to provide scientific research, testing, training, and product development services to...
This is a delivery order awarded under a $3,500,000 indefinite-delivery, indefinite-quantity (IDIQ) contract with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract is for the Diagnostics Pre-Clinical Services Program and is a firm fixed-price arrangement. The prime contractor is Mriglobal, a 501(c)(3) not-for-profit research organization that provides scientific research, testing, training, and product...
This is a $500,000.00 definitive contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The contract is for IGF::OT::IGF FOR OTHER FUNCTIONS with a completion date of September 24, 2019. It is a firm fixed-price contract and was not set aside for any specific business type. Mriglobal conducts over $110 million in research annually for...
This is a firm fixed-price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract, valued at $114,620.00, is for a Laboratory Research Network Proficiency Testing Program, with a period of performance through April 6, 2017. Mriglobal is a prime contractor with expertise in areas such as medical countermeasure development, biosafety testing,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $7,224,693.00 definitive cost contract to the Translational Genomics Research Institute (TGen), a non-profit biomedical research organization. The contract is for "MYCOBACTERIUM TUBERCULOSIS PROTEOME-WIDE EPITOPE DISCOVERY AND HOST TRANSCRIPTOME-WIDE T CELL PHENOTYPING IN HIGH DISEASE BURDEN POPULATIONS" and has an ultimate completion date of September 29, 2025. The contract does not have...
This award is a BPA (Blanket Purchase Agreement) call made by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The contract has a potential value of $112,665.00 and a completion date of July 30, 2020. It was awarded on a Firm Fixed Price basis with no set-aside designation. Mriglobal is an experienced federal contractor, having received numerous...